
Sevinç Balli/researchgate.net
Apr 4, 2025, 17:22
Sevinç Balli: Low dose Nivolumab maybe an option?
Sevinç Balli, Medical Oncologist at Ankara University, shared JCO Global Oncology’s post on X:
“Low dose Nivolumab maybe an option?”
Quoting JCO Global Oncology’s post on X about a recent paper by Praveen Kumar Marimuthu et al. published in ASCO Publications:
Authors: Praveen Kumar Marimuthu et al.
Ajoy Oommen John
and Ashish Singh.
Anjana Joel
Aparna Irodi
Balamugesh Thangakunam
Balukrishna Sasidharan
Barney T.J. Isaac
cancer
Deepa Susan Joy Philip
Divya Bala Thumaty
Jansi Rani
JCO Global Oncology
Josh Thomas Georgy
Kovilapu Harikrishna
Lung cancer
Manu Mathew
NSCLC
OncoDaily
Oncology
Prashant Jambunathan
Praveen Kumar Marimuthu
Rajesh Isiah
Raju Titus Chacko
Richa Gupta
Sevinc Balli
Simon Pradeep Pavamani
Thomas Alex Kodiatte
Zachariah Thomas
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 4, 2025, 17:22
Apr 4, 2025, 15:01
Apr 4, 2025, 14:54
Apr 4, 2025, 14:21
Apr 4, 2025, 13:45
Apr 4, 2025, 13:43